Home > National Drug Code (NDC) > Pentoxifylline

Pentoxifylline - 0093-5116-05 - (Pentoxifylline)

Alphabetical Index


Drug Information of Pentoxifylline

Product NDC: 0093-5116
Proprietary Name: Pentoxifylline
Non Proprietary Name: Pentoxifylline
Active Ingredient(s): 400    mg/1 & nbsp;   Pentoxifylline
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Pentoxifylline

Product NDC: 0093-5116
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075028
Marketing Category: ANDA
Start Marketing Date: 19980731

Package Information of Pentoxifylline

Package NDC: 0093-5116-05
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5116-05)

NDC Information of Pentoxifylline

NDC Code 0093-5116-05
Proprietary Name Pentoxifylline
Package Description 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5116-05)
Product NDC 0093-5116
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Pentoxifylline
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19980731
Marketing Category Name ANDA
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name PENTOXIFYLLINE
Strength Number 400
Strength Unit mg/1
Pharmaceutical Classes Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE]

Complete Information of Pentoxifylline


General Information